Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.9200 (6.18%) ($2.9200 - $2.9400) on Thu. Feb. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.77% (three month average) | RSI | 45 | Latest Price | $2.9200(6.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.4% a day on average for past five trading days. | Weekly Trend | CGEN declines -5.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(86%) IWO(84%) QQQ(84%) SKYY(84%) ARKG(81%) | Factors Impacting CGEN price | CGEN will decline at least -1.885% in a week (0% probabilities). VIXM(-78%) VXX(-58%) UUP(-30%) EDOC(-20%) GLD(-12%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.885% (StdDev 3.77%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.39(-455.82%) | Resistance Level | $3.13 | 5 Day Moving Average | $2.85(2.46%) | 10 Day Moving Average | $2.98(-2.01%) | 20 Day Moving Average | $3.13(-6.71%) | To recent high | -37.9% | To recent low | 6.2% | Market Cap | $241m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |